pharma.us.novartis.comNovartis United States of America
pharma.us.novartis.com Profile
Pharma.us.novartis.com is a subdomain of novartis.com,
which was created on 1996-04-02,making it 28 years ago.
It has several subdomains, such as ngcs.novartis.com
securemail.novartis.com , among others.
Description：Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients...
Keywords：novartis united states of america, innovation, novartis...
Discover pharma.us.novartis.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
pharma.us.novartis.com Information
| HomePage size: 182.898 KB |
| Page Load Time: 0.871966 Seconds |
| Website IP Address: 172.64.154.11 |
pharma.us.novartis.com Similar Website
| United States Mission to the United Nations |
| United States of America Local Business Directory |
| KIOXIA America, Inc. - Home | KIOXIA - United States (English) |
| The Humane Society of The United States | The Humane Society of the United States |
| Novartis Data Exchange Hompage |
| Home - Novartis |
| MileSplit United States | United States High School Running News and Videos | Cross Country and Trac |
| United States Dollar(USD) Exchange Rates Today - United States Dollar Currency Converter - FX Exchan |
| Novartis |
| United States escorts - Female escorts in United States - EscortsAffair |
| EB5 VISA IN UNITED STATES – EB5 VISA IN UNITED STATES – GET YOUR |
pharma.us.novartis.com Httpheader
| Date: Tue, 14 May 2024 23:33:16 GMT |
| Content-Type: text/html; charset=UTF-8 |
| Transfer-Encoding: chunked |
| Connection: keep-alive |
| Cache-Control: public, max-age=18000 |
| content-language: en |
| x-content-type-options: nosniff |
| x-frame-options: SAMEORIGIN |
| expires: Wed, 15 May 2024 04:33:16 GMT |
| last-modified: Tue, 14 May 2024 23:31:59 GMT |
| vary: Cookie,Accept-Encoding |
| content-security-policy-report-only: "script-src self unsafe-inline unsafe-eval https://unpkg.com https://acsbapp.com https://snap.licdn.com https://maps.googleapis.com https://static.ads-twitter.com https://analytics.twitter.com https://connect.facebook.net https://cdn.cookielaw.org https://www.youtube.com https://static.addtoany.com https://cdnjs.cloudflare.com https://www.googletagmanager.com https://js-agent.newrelic.com https://geolocation.onetrust.com https://bam-cell.nr-data.net https://cdnsecakmi.kaltura.com https://cdnapisec.kaltura.com http://cdnapi.kaltura.com https://www.google-analytics.com https://cdn.jsdelivr.net https://script.crazyegg.com https://static.cloudflareinsights.com https://www.google.com https://www.gstatic.com https://bam.nr-data.net https://hm.baidu.com/hm.js blob:; object-src self unsafe-inline unsafe-eval https: data; style-src self unsafe-inline unsafe-eval https://cdn.cookielaw.org https://acsbapp.com https://maps.googleapis.com https://fonts.googleapis.com https://www.youtube.com https://static.addtoany.com https://cdnjs.cloudflare.com https://www.googletagmanager.com https://js-agent.newrelic.com https://geolocation.onetrust.com https://bam-cell.nr-data.net https://script.crazyegg.com https://static.cloudflareinsights.com https://cdnapisec.kaltura.com; frame-ancestors self; report-uri /us-en/report-csp-violation", x-xss-protection: 1; mode=block |
| strict-transport-security: max-age=31536000; includeSubDomains |
| x-request-id: v-28a64dd2-124a-11ef-81ff-3bb221ae60a3 |
| x-ah-environment: prod |
| via: varnish |
| x-cache: HIT |
| x-cache-hits: 2 |
| CF-Cache-Status: EXPIRED |
| Server: cloudflare |
| CF-RAY: 883eb1332d10efca-PDX |
pharma.us.novartis.com Meta Info
| charset="utf-8"/ |
| content="Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide." name="description"/ |
| content="novartis united states of america, innovation, novartis digital" name="keywords"/ |
| content="Novartis United States of America" property="og:site_name"/ |
| content="Website" property="og:type"/ |
| content="https://www.novartis.com/us-en/home" property="og:url"/ |
| content="Novartis United States of America" property="og:title"/ |
| content="Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide. At Novartis, we reimagine medicine in the broadest possible sense, from finding innovative treatments that improve and extend people’s lives, to making our healthcare system more accessible and equitable for all. We put special emphasis on developing sustainable solutions that address the root causes of healthcare disparities and inequities, using new tools, approaches and perspectives to drive meaningful change." property="og:description"/ |
| content="https://www.novartis.com/us-en/sites/novartis_us/files/2023-11/novartis-animated-logo-1x.gif" property="og:image"/ |
| content="https://www.novartis.com/us-en/sites/novartis_us/files/2023-11/novartis-animated-logo-1x.gif" property="og:image:url"/ |
| content="https://www.novartis.com/us-en/sites/novartis_us/files/2023-11/novartis-animated-logo-1x.gif" property="og:image:secure_url"/ |
| content="At Novartis, we reimagine medicine in the broadest possible sense, from finding innovative treatments that improve and extend people’s lives, to making our healthcare system more accessible and equitable for all. We put special emphasis on developing sustainable solutions that address the root causes of healthcare disparities and inequities, using new tools, approaches and perspectives to drive meaningful change." property="og:image:alt"/ |
| content="summary" name="twitter:card"/ |
| content="Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide." name="twitter:description"/ |
| content="@novartis" name="twitter:site"/ |
| content="Novartis United States of America" name="twitter:title"/ |
| content="17226612" name="twitter:site:id"/ |
| content="@novartis" name="twitter:creator"/ |
| content="17226612" name="twitter:creator:id"/ |
| content="https://www.novartis.com/us-en/home" name="twitter:url"/ |
| content="https://www.novartis.com/sites/novartis_com/files/novartis-logo-open-graph.jpg" name="twitter:image"/ |
| content="At Novartis, we reimagine medicine in the broadest possible sense, from finding innovative treatments that improve and extend people’s lives, to making our healthcare system more accessible and equitable for all. We put special emphasis on developing sustainable solutions that address the root causes of healthcare disparities and inequities, using new tools, approaches and perspectives to drive meaningful change." name="twitter:image:alt"/ |
| content="width" name="MobileOptimized"/ |
| content="true" name="HandheldFriendly"/ |
| content="width=device-width, initial-scale=1, shrink-to-fit=no" name="viewport"/ |
| content="ie=edge" http-equiv="x-ua-compatible"/ |
pharma.us.novartis.com Html To Plain Text
Search United States | en Choose Location Americas Asia Pacific Europe International Middle East & Africa Argentina | Español Brazil | Português Canada | English Canada | Français Central America | Español Colombia | Español Mexico | Español United States | English Australia | English Bangladesh | English Hong Kong S.A.R. | 繁體中文 India | English Indonesia | English Japan | 日本語 Korea | 한국어 Mainland China | 中文 Malaysia | English Pakistan | English Philippines | English Singapore | English Taiwan | 繁體中文 Thailand | ภาษาไทย Austria | Deutsch Belgium | Français Belgium | Nederlands Bulgaria | Български Czech Republic | Česky Czech Republic | English Denmark | Dansk Estonia | Eesti Finland | Suomalainen France | Français Germany | Deutsch Greece | Ελληνικά Hungary | Magyar Ireland | English Italy | Italiano Latvia | Latvian Lithuania | Lithuanian Netherlands | Nederlands Norway | Norsk Poland | Polski Portugal | Português Romania | Română Russia | Русский Serbia | Srpski Slovakia | Slovensky Slovenia | Slovenščina Slovenia | English Spain | Español Sweden | Svenska Switzerland | Deutsch Switzerland | Français Türkiye | Türkçe United Kingdom | English Global | English Novartis Foundation | English Egypt | English Israel | עברית Saudi Arabia | العربية South Africa | English us Choose Location americas Americas Asia Pacific Europe International Middle East & Africa Argentina | Español Australia | English Austria | Deutsch Bangladesh | English Belgium | Français Belgium | Nederlands Brazil | Português Bulgaria | Български Canada | English Canada | Français Central America | Español Colombia | Español Czech Republic | Česky Czech Republic | English Denmark | Dansk Egypt | English Estonia | Eesti Finland | Suomalainen France | Français Germany | Deutsch Greece | Ελληνικά Hong Kong S.A.R. | 繁體中文 Hungary | Magyar India | English Indonesia | English Ireland | English Israel | עברית Italy | Italiano Japan | 日本語 Korea | 한국어 Latvia | Latvian Lithuania | Lithuanian Mainland China | 中文 Malaysia | English Mexico | Español Netherlands | Nederlands Norway | Norsk Global | English Novartis Foundation | English Pakistan | English Philippines | English Poland | Polski Portugal | Português Romania | Română Russia | Русский Saudi Arabia | العربية Serbia | Srpski Singapore | English Slovakia | Slovensky Slovenia | Slovenščina Slovenia | English South Africa | English Spain | Español Sweden | Svenska Switzerland | Deutsch Switzerland | Français Taiwan | 繁體中文 Thailand | ภาษาไทย Türkiye | Türkçe United Kingdom | English United States | English Menu About Novartis in the US Company at a glance By the numbers Diversity and inclusion Pay transparency-EPIC Our code of ethics Strategy Diversity and inclusion Ensuring equity The spirit of inclusivity Toward a better society Parental leave Standing for racial equity and justice as one Novartis Novartis US EEO / D&I report 2021 Supplier diversity People and culture Products US Country Coordinating Committee External funding Contact us About Patients and caregivers Novartis commitment to patients and caregivers Patient assistance Diseases Chronic spontaneous urticaria (CSU) Hidradenitis suppurativa (HS) Participating in clinical trials Patient perspectives Adverse event reporting The STEP program Sickle cell disease (SCD) Program overview Multiple sclerosis (MS) Cancer Application for funding to help address health disparities Health disparities Novartis patient support for oncology Patient resources Patients and caregivers Healthcare professionals Novartis pipeline Novartis clinical trials Adverse event reporting Novartis patient support for oncology HCP resources Healthcare professionals ESG Ethical behavior Code of ethics SpeakUp PhRMA Code on interactions with healthcare professionals Business principles Ethics, risk and compliance Compliance program State laws Corporate integrity agreement Payments to HCPs & HCOs Enhanced verification request Corporate responsibility Population health Novartis in society US reports Novartis US Foundation Environmental sustainability People and communities Beacon of hope Beacon of hope: Measurable solutions for health equity Paving the way for a brighter, more equitable future ESG News News archive Statements Stories Contacts News Careers Career search Meet the teams Early career Personal growth How we work Employee benefits Diversity and inclusion Awards & recognition Careers Home Header Novartis United States Working together, we can reimagine medicine to improve and extend people’s lives. Novartis Financial Results – Q1 2024 Novartis announced the company’s financial results for the first quarter of 2024. Learn more Novartis in Society Integrated Report 2023 This report covers our business, strategy, and performance. It highlights progress against our ESG targets and describes how we create sustainable value for diverse stakeholders. It follows requirements of the Swiss Code of Obligations and various voluntary reporting frameworks and standards.At Novartis, we are united by a single purpose to reimagine medicine to improve and extend people’s lives. Drug delivery, service delivery, and the future of cancer care State-of-the-art Novartis manufacturing facility in Indianapolis fortifies the foundation of an entirely new paradigm in pharmaceutical drug delivery. Read more Beacon of Hope Novartis is expanding the Beacon of Hope program through new collaborations to address systemic health disparities. Learn more Patient Support for Oncology Novartis Patient Support for Oncology can help you on treatment. Contact Us Find information on our research locations and corporate offices in US. Careers 769 million lives touched by our products. Join us. Latest News Apr 23, 2024 Novartis radioligand therapy Lutathera® FDA approved as first medicine specifically for pediatric patients with gastroenteropancreatic neuroendocrine tumors Apr 17, 2024 Novartis Kesimpta® six-year efficacy data show substantial benefits in recently diagnosed treatment-naïve people with relapsing multiple sclerosis Apr 15, 2024 New Novartis Fabhalta® (iptacopan) data show clinically meaningful and statistically significant proteinuria reduction of 38.3% versus placebo for patients with IgA nephropathy (IgAN) View more Novartis United States Navigate Novartis Navigate Novartis Patients & caregivers Healthcare professionals ESG News Careers Media center Media center News archive Statements Stories Our portfolio Our portfolio Novartis clinical pipeline Novartis product portfolio Other Novartis US websites Other Novartis US websites Oncology HCP resources Medical information Global site Search Footer Bottom Footer Bottom © 2024 Novartis Pharmaceuticals Corporation Terms of use Privacy policy Consumer health privacy policy Contacts Site map Web accessibility Novartis Site Directory This site is intended for US residents...
pharma.us.novartis.com Whois
Domain Name: NOVARTIS.COM Registry Domain ID: 2845657_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.markmonitor.com Registrar URL: http://www.markmonitor.com Updated Date: 2022-10-16T09:03:11Z Creation Date: 1996-04-02T05:00:00Z Registry Expiry Date: 2024-11-17T17:29:14Z Registrar: MarkMonitor Inc. Registrar IANA ID: 292 Registrar Abuse Contact Email: abusecomplaints@markmonitor.com Registrar Abuse Contact Phone: +1.2086851750 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Domain Status: serverDeleteProhibited https://icann.org/epp#serverDeleteProhibited Domain Status: serverTransferProhibited https://icann.org/epp#serverTransferProhibited Domain Status: serverUpdateProhibited https://icann.org/epp#serverUpdateProhibited Name Server: A1-254.AKAM.NET Name Server: A2-66.AKAM.NET Name Server: A24-65.AKAM.NET Name Server: A28-67.AKAM.NET Name Server: A7-64.AKAM.NET Name Server: A9-65.AKAM.NET Name Server: DNS1.NOVARTIS.COM Name Server: DNS2.NOVARTIS.COM Name Server: DNS3.NOVARTIS.COM Name Server: DNS4.NOVARTIS.COM DNSSEC: unsigned >>> Last update of whois database: 2024-05-17T19:10:10Z <<<